Stalevo 150/37.5/200mg Tablet 100s (Bottle)

Stalevo 150/37.5/200mg Tablet 100s (Bottle) belongs to the drug class of dopaminergic antiparkinsonism agents. It combines three active ingredients - carbidopa, levodopa, and entacapone - which work collectively to manage the symptoms of Parkinson's disease. Carbidopa prevents the levodopa from being broken down in the peripheral tissues, increasing its availability in the brain. Levodopa is converted into dopamine, a neurotransmitter that is lacking in Parkinson's disease, thereby alleviating its symptoms. Entacapone further prolongs the action of levodopa by inhibiting an enzyme that breaks it down in the body. Some common side effects of Stalevo 150/37.5/200mg Tablet 100s (Bottle) include nausea, dizziness, insomnia, and dyskinesia. Patients are advised to follow their healthcare provider's instructions and to avoid sudden discontinuation of the medication. Regular monitoring and dose adjustments may be necessary to achieve optimal therapeutic outcomes.

Stalevo 150/37.5/200mg Tablet 100s (Bottle) is indicated for the management of the symptoms of Parkinson's disease, a neurodegenerative disorder characterized by a loss of dopamine-producing cells in the brain. The combination of carbidopa, levodopa, and entacapone in Stalevo 150/37.5/200mg Tablet 100s (Bottle) helps to increase dopamine levels in the brain, thereby reducing the signs and symptoms associated with Parkinson's disease.

Stalevo 150/37.5/200mg Tablet 100s (Bottle) should be taken orally with or without food. The tablet should be swallowed whole and not crushed or chewed. The specific dosing instructions for Stalevo 150/37.5/200mg Tablet 100s (Bottle) may vary depending on the individual patient's needs, so it is important to follow the healthcare provider's recommendation for dose and frequency.

The recommended dosage range for Stalevo 150/37.5/200mg Tablet 100s (Bottle) is based on individual patient response and tolerability. It is generally initiated at a low dose and gradually increased until optimal symptom control is achieved. The frequency of dosing may also vary depending on the patient's needs. It is essential to follow the healthcare provider's instructions regarding the dosing and administration of Stalevo 150/37.5/200mg Tablet 100s (Bottle).

The shelf life of Stalevo 150/37.5/200mg Tablet 100s (Bottle) refers to the period during which the medication is considered safe and effective to use. To determine the specific shelf life, please refer to the packaging or consult with the healthcare provider or pharmacist.

Stalevo 150/37.5/200mg Tablet 100s (Bottle) should be stored at room temperature, away from direct sunlight and moisture. It is essential to keep the medication out of reach of children and pets. To maintain the quality and effectiveness of Stalevo 150/37.5/200mg Tablet 100s (Bottle), it is recommended to store it in its original packaging until use.

• Nausea
• Dizziness
• Insomnia
• Dyskinesia

Stalevo 150/37.5/200mg Tablet 100s (Bottle) is contraindicated in patients with a history of hypersensitivity to any of its components. It should not be used in patients receiving nonselective, irreversible monoamine oxidase (MAO) inhibitors or within 14 days of discontinuing these inhibitors. Stalevo 150/37.5/200mg Tablet 100s (Bottle) is also contraindicated in patients with narrow-angle glaucoma.

Stalevo 150/37.5/200mg Tablet 100s (Bottle) may interact with other medications and certain foods, potentially altering its efficacy or increasing the risk of side effects. Patients should inform their healthcare provider about all current medications, including over-the-counter drugs and herbal supplements, to avoid potential interactions. Stalevo 150/37.5/200mg Tablet 100s (Bottle) should not be taken with nonselective, irreversible monoamine oxidase (MAO) inhibitors or high-protein meals since it may reduce its absorption and efficacy.

• Take Stalevo 150/37.5/200mg Tablet 100s (Bottle) as prescribed by your healthcare provider.
• Do not suddenly stop taking Stalevo 150/37.5/200mg Tablet 100s (Bottle) without consulting your doctor.
• Be cautious while driving or operating machinery as Stalevo 150/37.5/200mg Tablet 100s (Bottle) may cause dizziness or drowsiness.
• Maintain proper hydration and follow a balanced diet to optimize the effects of Stalevo 150/37.5/200mg Tablet 100s (Bottle).
• Keep regular follow-up appointments with your healthcare provider for monitoring and dose adjustments as necessary.

1. Can Stalevo 150/37.5/200mg Tablet 100s (Bottle) completely cure Parkinson's disease?
2. No, Stalevo 150/37.5/200mg Tablet 100s (Bottle) helps in managing the symptoms of Parkinson's disease but does not provide a cure for the condition.
3. Can I suddenly stop taking Stalevo 150/37.5/200mg Tablet 100s (Bottle) if I feel better?
4. No, sudden discontinuation of Stalevo 150/37.5/200mg Tablet 100s (Bottle) may lead to a worsening of Parkinson's disease symptoms. It is important to consult your healthcare provider before making any changes to your medication regimen.
5. Can Stalevo 150/37.5/200mg Tablet 100s (Bottle) be taken with other Parkinson's disease medications?
6. The concomitant use of Stalevo 150/37.5/200mg Tablet 100s (Bottle) with other Parkinson's disease medications should be done under the supervision of a healthcare professional, as adjustments in dosing and timing may be necessary to avoid potential interactions or side effects.